Media Database
>
Antonio Regalado

Antonio Regalado

Senior Editor, Biomedicine at MIT Technology Review

Contact this person
Email address
a*****@*******.comGet email address
Influence score
53
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
    Covering topics
    • Biotechnology

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    technologyreview.com

    Here’s the latest company planning for gene-edited babies

    Entrepreneurs say it’s time to safety-test designer baby technology.
    technologyreview.com

    The astonishing embryo models of Jacob Hanna

    Scientists are creating the beginnings of bodies without sperm or eggs. How far should they be allowed to go?
    technologyreview.com

    This retina implant lets people with vision loss do a crossword puzzle

    Competition to deploy commercial brain-computer interfaces is heating up.
    technologyreview.com

    Microsoft says AI can create “zero day” threats in biology

    Artificial intelligence can design toxins that evade security controls.
    technologyreview.com

    AI-designed viruses are here and already killing bacteria

    Can AI create a life form? These “generative” genomes are a start
    technologyreview.com

    I gave the police access to my DNA—and maybe some of yours

    I gave the police access to my DNA—and maybe some of yours
    technologyreview.com

    Google’s new AI will help researchers understand how our genes work

    First came AlphaFold. Now comes AlphaGenome for DNA.
    technologyreview.com

    Crypto billionaire Brian Armstrong is ready to invest in CRISPR bab...

    The stigmatized idea could get a massive boost from “tech bros”—and some scientists are cheering them on.
    technologyreview.com

    This baby boy was treated with the first personalized gene-editing ...

    The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely rare genetic diseases.
    technologyreview.com

    A US court just put ownership of CRISPR back in play

    At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the age and credit for inventing it.
    technologyreview.com

    This patient’s Neuralink brain implant gets a boost from generative AI

    A patient who types with his brain thanks to a Neuralink implant is using AI chatbots to speed things up.